Innovacell is a biotechnology firm focused on cell-tissue therapy for the treatment of incontinence.
Innovacell has raised $2.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2025.
Innovacell's investors include Fundinno, Rheos, Buschier, Uni Venture.
Innovacell is headquartered in Innsbruck, Austria.
Innovacell is a biotechnology firm focused on cell-tissue therapy for the treatment of incontinence.
Innovacell is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Innovacell — Funding & Investors." VCBacked, April 30, 2025, https://www.vcbacked.co/company/innovacell. Accessed November 14, 2026.
VCBacked. (2025). Innovacell — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/innovacell
{{cite web |title=Innovacell — Funding & Investors |url=https://www.vcbacked.co/company/innovacell |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Innovacell? Request a listing update